Study List:

Study 1:
  NCT Number:                   NCT00345267
  Title:                        Effect of an Integrated Care Pathway on Asthma Care in Hospital
  Acronym:                      
  Status:                       Completed
  Study Results:                No Results Available
  Conditions:                   Asthma
  Interventions:                Device: Integrated Care Pathway
  Outcome Measures:             Length of stay in hospital|Speed of recovery of heart rate and respiratory rate|Time to require no supplemental oxygen|Time to achieve 4 hourly spacing of bronchodilator|Number and degree of prescribing errors|Provision of education to parents|Provision of care adhering to asthma guidelines (accurate discharge dose of prednisolone from emergency dept, use of multidose salbutamol rather than nebuliser)|Number of clinical contacts required with patients|Staff opinion of ICP before and after introduction|Parental opinion of care in different groups|Parental recall of advice/education provided to them during admission|Possible Hawthorne effect during period of the study|Parental recall of advice to contact primary care
  Sponsor/Collaborators:        University of Edinburgh|Roche Educational Grant|Edinburgh Sick Kids Friends Foundation
  Gender:                       All
  Age:                          2 Years to 16 Years   (Child)
  Phases:                       Not Applicable
  Enrollment:                   180
  Funded Bys:                   Other
  Study Type:                   Interventional
  Study Designs:                Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
  Other IDs:                    04/S1103/16
  Start Date:                   August 2004
  Primary Completion Date:      
  Completion Date:              March 2005
  First Posted:                 June 28, 2006
  Results First Posted:         
  Last Update Posted:           June 28, 2006
  Locations:                    Dept of Respiratory and Sleep Medicine, Royal Hospital for Sick Children, Edinburgh, Scotland, United Kingdom
  Study Documents:              
  URL:                          https://ClinicalTrials.gov/show/NCT00345267

Study 2:
  NCT Number:                   NCT01954212
  Title:                        Stroke Oral healthCare pLan Evaluation
  Acronym:                      SOCLE II
  Status:                       Completed
  Study Results:                No Results Available
  Conditions:                   Cerebrovascular Disorders|Stroke|Pneumonia|Oral Hygiene
  Interventions:                Other: Enhanced complex oral health care
  Outcome Measures:             Pneumonia|Oral Health Impact Profile|Dental plaque|Denture plaque|Antibiotics prescribed|Death
  Sponsor/Collaborators:        Glasgow Caledonian University|Nursing Midwifery and Allied Health Profession (NMAHP) Research Unit|University of Glasgow|NHS Lanarkshire|Glasgow Dental Hospital and School|University of Edinburgh
  Gender:                       All
  Age:                          Child, Adult, Older Adult
  Phases:                       Phase 2
  Enrollment:                   437
  Funded Bys:                   Other
  Study Type:                   Interventional
  Study Designs:                Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research
  Other IDs:                    TSA 2012/09
  Start Date:                   October 2013
  Primary Completion Date:      April 2015
  Completion Date:              April 2016
  First Posted:                 October 1, 2013
  Results First Posted:         
  Last Update Posted:           February 28, 2017
  Locations:                    Hairmyres Hospital, East Kilbride, Lanarkshire, United Kingdom|Wishaw General Hospital, Wishaw, Lanarkshire, United Kingdom|Stobhill Hospital, Glasgow, Scotland, United Kingdom|Royal Alexandra Hospital, Paisley, Scotland, United Kingdom
  Study Documents:              
  URL:                          https://ClinicalTrials.gov/show/NCT01954212

Study 3:
  NCT Number:                   NCT01473563
  Title:                        A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
  Acronym:                      
  Status:                       Completed
  Study Results:                Has Results
  Conditions:                   Nonsquamous Non-Small Cell Neoplasm of Lung|Non-Small Cell Lung Cancer Metastatic|Non-Small Cell Lung Cancer Stage IIIB
  Interventions:                Drug: Pemetrexed
  Outcome Measures:             Percentage of Participants Who Adhered to Treatment Administration at Home|Change From Baseline in the European Quality of Life Instrument (EQ-5D) Visual Analogue Scale (VAS)|Change From Baseline in the EQ-5D Index Score|Maximum Improvement Over Baseline in Individual Lung Cancer Symptoms Scale (LCSS) Item Scores|Participant Satisfaction: Chemotherapy at Hospital|Participant Satisfaction: Chemotherapy at Home|Participant Satisfaction: Regarding the Study Nurse|Participant Satisfaction: Preferences Regarding Home and/or Hospital Treatment|Physician Satisfaction: Distant Management of Participant|Resource Utilization: Number of Participants With an Unplanned Use of Healthcare Resources|Resource Utilization: Unplanned Health Care Visits, Consultations, and Diagnostic Services|Resource Utilization: Duration of Health Care Visits|Resource Utilization: Distances Traveled|Overall Survival (OS) at 6 Months|Time to Treatment Failure (TTF)
  Sponsor/Collaborators:        Eli Lilly and Company
  Gender:                       All
  Age:                          18 Years and older   (Adult, Older Adult)
  Phases:                       Phase 2
  Enrollment:                   52
  Funded Bys:                   Industry
  Study Type:                   Interventional
  Study Designs:                Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)
  Other IDs:                    14079|H3E-EW-S133
  Start Date:                   December 2011
  Primary Completion Date:      September 2013
  Completion Date:              September 2013
  First Posted:                 November 17, 2011
  Results First Posted:         October 6, 2014
  Last Update Posted:           October 6, 2014
  Locations:                    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Linkoping, Sweden|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Solna, Sweden|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, Greater London, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Maidstone, Kent, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nottingham, Nottinghamshire, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Aberdeen, Scotland, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Huddersfield, West Yorkshire, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Manchester, United Kingdom
  Study Documents:              
  URL:                          https://ClinicalTrials.gov/show/NCT01473563

